UCB stock price target raised to EUR285 by Deutsche Bank on galvokimig data
PositiveFinancial Markets

Deutsche Bank has raised its stock price target for UCB to EUR 285, driven by promising data on galvokimig. This adjustment reflects confidence in UCB's potential and highlights the positive outlook for their developments in the pharmaceutical sector. Investors may find this news encouraging as it suggests a strong performance ahead for the company.
— Curated by the World Pulse Now AI Editorial System